EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
With Pseudoscience Reigning, Debunker Offers Tips For Fighting Back 06/05/2025
FDA Not Recommending Newly Approved COVID-19 Vaccine: Official | ZeroHedge
Case: Patents/Claim Construction (Fed. Cir.)
US appeals court sides with Moderna on COVID patent claims
Fed Circ upholds Moderna's COVID-19 vaccine win against Alnylam
Alnylam Fails to Revive Patent Infringement Suit Against Moderna
Pharma execs speak out: UK pricing rebates scare investors | BioWorld
Alpha Wealth Funds LLC Buys Shares of 15,000 Moderna, Inc. (NASDAQ:MRNA)
US Fed Circuit rules in favor of Moderna in patent squabble | BioWorld
HHS axes $776 million Moderna bird flu vaccine deal over safety, ethical concerns - NaturalNews.com
Moderna Will Test New Covid Shot Against Placebo, RFK Says (1)
Moderna's (MRNA) "Market Perform" Rating Reaffirmed at William Blair
LVW Advisors LLC Invests $298,000 in Moderna, Inc. (NASDAQ:MRNA)
How Moderna went From pandemic hero to vaccine victim
Moderna (MRNA) Faces Multiple Regulatory Challenges
Brad Miller Joins Keystone as President of CoreAI | Morningstar
Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash | ZeroHedge
Douglas Lane & Associates LLC Buys 99,713 Shares of Moderna, Inc. (NASDAQ:MRNA)
Moderna Shares Rise on FDA Approval of Covid-19 Vaccine | Morningstar
Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine | Fox News
Moderna Shares Gain On FDA Approval For New COVID-19 Vaccine
Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (OtherCHJTF) and Moderna (MRNA) | Markets Insider
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19 | Markets Insider
CDC confirms ample supply of COVID-19 drugs, vaccines - Focus Taiwan
US FDA approves Moderna's new lower-dose Covid-19 vaccine 'mNexspike' | Health News - Business Standard
Moderna's new lower-dose COVID-19 vaccine approved by FDA
Investors Buy High Volume of Call Options on Moderna (NASDAQ:MRNA)
US approves new lower-dose COVID-19 vaccine made by Moderna
FDA Approves Moderna COVID Vaccine for Adults 65 or Older | Newsmax.com
HIV's Most Promising Breakthrough Has Taken a Hit
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by California State Teachers Retirement System
FDA Covid Update: Moderna's New mNEXSPIKE Vaccine Approved for Seniors
US approves new Moderna Covid jab for over-65s
Coronavirus Vaccine: New COVID vaccine approved by US FDA: Here's all about it | - Times of India
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | Morningstar
US authorities approve Moderna's new COVID vaccine - Statement
Moderna wins narrower US approval for new COVID vaccine | Health & Fitness | ArcaMax Publishing
HHS cancels funding for Moderna vaccines to fight pandemic flu
New COVID variant NB.1.8.1: New COVID variant NB.1.8.1 spreading fast in the U.S - is your vaccine effective? Will there be a summer surge? - The Economic Times
Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript
Why is Trump's administration cutting bird flu vaccine funding? - CBS News
HHS axes $700M Moderna bird flu vaccine contract - is this a pivot to more dangerous, self-replicating mRNA jabs? - NaturalNews.com
Trump administration pulls bird flu, other vaccine funding awarded to Moderna
US ends $590 mn Moderna deal to develop bird flu vaccine using mRNA tech | World News - Business Standard
US cancels $766-M Moderna vaccine contract | The Manila Times
U.S. Ends $600M Moderna Bird Flu Vaccine Contract
US Cancels $700 Million Moderna Bird Flu Vaccine Contract
Trump administration cancels funding for Moderna bird flu vaccine
Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results - CBS Minnesota
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update | Morningstar
US Cancels $590 Million Contract With Moderna for Bird Flu Shot | Newsmax.com
US cancels $590 million contract with Moderna for bird flu shot | The Manila Times
HHS terminating Moderna's $590M grant for flu vaccines | BioWorld
US cancels over $700mn funding for Moderna bird flu vaccine
US cancels US$590 million contract with Moderna for bird flu shot - CNA
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
US cancels $700m in funding for Moderna's bird flu vaccine
Trump administration cancels $766 million Moderna contract to fight pandemic flu
Moderna's $766 million pandemic flu vaccine contract canceled by Trump administration
Trump administration pulls the plug on the bird flu vaccine : NPR
HHS cuts funding to 'under-tested' mRNA technology for bird flu vaccines | Fox News
US Cancels $700M Funding for Moderna's Bird Flu Vaccine, Moderna to Explore Alternatives
Trump admin cancels $766m Moderna contract to fight pandemic flu
The New Legal Battle Over Trump's Sweeping Tariffs | The Fiscal Times
HHS cancels funding for Moderna to develop vaccines to combat bird flu
HHS to Terminate Moderna Late Stage Flu Vaccine Award | Morningstar
US cancels more than US$700 million funding for Moderna bird flu vaccine
HHS Cancels $766 Million in Funds for Moderna Bird Flu Shot (1)
Moderna confirms HHS to terminate flu vaccine award | Markets Insider
HHS to cancel nearly $600M Moderna flu vaccine contract, STAT reports | Markets Insider
U.S. Ends Funding For Moderna's Influenza Vaccine; Moderna Explores Alternatives For H5 Program
Assessing Your Talent Needs in the Age of AI
What is Zacks Research's Estimate for Moderna Q2 Earnings?
HHS cancels Moderna's $590 million contract for bird flu vaccine | News & Features | ArcaMax Publishing
CDC ends Covid vaccine recommendation for healthy kids and pregnant women
Moderna entities must face infringement suits, UPC rules
Moderna to Present at Upcoming Conferences in June 2025 | Morningstar
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Two Sigma Advisers LP
AI-Driven mRNA Therapeutics Market Development Accelerated by AI Integration in Drug Design Delivery and Scalable Manufacturing
Jim Cramer on Moderna (MRNA): "I've Been Against This Stock For So Long" - Insider Monkey
Moderna withdraws flu-COVID vaccine application amid heightened FDA scrutiny - NaturalNews.com
U.S. Senator on Trump: 'That was the emergency he came up with' | Watch News Videos Online
Carney is 'doing things a little differently' | Watch News Videos Online
Moderna's updated Covid vaccine for review | The Manila Times
JPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $26.00
Latest news
Show more
Morning Note: ECB Rate Cut Expected; Canada PMI in Focus; EUR/USD, USD/CAD
Morning Note: ECB Rate Cut Expected; Broadcom Earnings; Oil Falls on Supply
